Episode 1

What they fund

Pre-Seed and Seed B2B software companies raising early rounds [1], Companies leveraging AI in manufacturing, logistics, or health-tech [1], UK-based founders with a 'go-all-in' mindset [1], Firms seeking capital-efficient validation and Series A preparation [1], Founders willing to endure cash flow crunches and sleepless nights [1]

Investment thesis

Episode 1 targets early-stage B2B software and SaaS businesses, specifically those leveraging AI, operating in TechBio, health-tech, or infrastructure sectors [Profile]. The investment mandate is geographically constrained to the United Kingdom [Profile]. The check size range of £250k – £3M suggests a thesis focused on capital-efficient early validation and seed-stage scaling rather than late-stage growth [Profile]. With a target pace of 15-20 investments per year, the firm prioritizes volume and speed in the 0-1 journey [Profile]. The firm builds relationships early, makes decisions quickly, and engages with founders for the long-term [Profile].

Credibility: The firm's website explicitly states its focus on Pre-Seed and Seed B2B software companies, its UK geographic constraint, and its £250k – £3M check size range [1].

Value add

Episode 1 brings the whole firm to support investments, providing consistent support through good and challenging times [1]. They offer guidance on go-to-market strategy and fundraising, which has been key to portfolio success [1]. Board members like Adrian act as active contributors, independent sounding boards, and constant cheerleaders [1]. The team is described as smart, approachable, and helpful, pulling out all stops to assist CEOs [1].

Fit verdict: Ideal for UK-based B2B software founders who value hands-on, operator-led support and a long-term partnership over passive capital.

Founder diligence script:

• How does Episode 1 allocate resources across its 65+ portfolio companies to ensure 'pulling out all stops' for each CEO?
• What specific mechanisms does the firm use to facilitate Series A fundraising for its portfolio companies?
• How does the firm's 'go-all-in' founder profile influence its decision-making process during cash flow crunches?
• What is the expected board involvement level for pre-seed investments versus seed investments?

Portfolio focus

Sano Genetics — personalised medicine [1], CloudNC — AI manufacturing co-pilot [1], Raft — automating the freight journey [1], Adsum — business tax refunds [1], Carwow — consumer automotive marketplace [1]

Notable investments & exits

Carwow — acquired by Auto Trader in 2021 for £1.1bn [1], FATMAP — acquired by Google in 2021 [1], Robin AI — acquired by Amazon in 2023 [1], Unison — acquired by Microsoft in 2022 [1], QuestDB — acquired by Snowflake in 2023 [1]

Strategic implications

Episode 1's edge lies in its operator-led, hands-on approach, which resonates with early-stage founders seeking more than capital. The firm's focus on UK-based B2B software creates a concentrated, deep network effect in a specific sector and geography. The signal that would change the read is a shift in geographic focus or a move into later-stage rounds, which would dilute its early-stage, operator-led value proposition.

Where they could go further

Expand geographic focus to include other English-speaking markets to scale the model beyond the UK., Develop a more structured co-investor program to leverage its network and reduce deal-by-deal sourcing costs., Create a dedicated fund for TechBio or infrastructure to capitalize on its stated thesis areas, which are currently underrepresented in its portfolio., Publish a more detailed report on its 'Outlier Quotient™' to attract more founders and differentiate its sourcing process.